VKTX   $68.19  5.79% Market Closed After Close 68.1 -0.13%

Viking Therapeutics Inc
Total Cash 942.26M
totalCashPerShare 8.504
EBITDA
Total Debt 1.10M
quickRatio 37.551
currentRatio 37.689
Total Revenue
debtToEquity 0.119
Revenue/Share
ROA -0.11565
ROE -0.14803
grossProfits
freeCashflow -39.39M
operatingCashflow -71.94M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 6.45B
forwardPE -44.192055
floatShares 104.73M
sharesOutstanding 110.80M
sharesShort 17.14M
sharesShortPriorMonth 16.86M
dateShortInterest
sharesPercentSharesOut 0.15%
heldPercentInsiders 0.06%
heldPercentInstitutions 0.75%
Short Ratio help_outline 5.12%
shortPercentOfFloat 0.21%
impliedSharesOutstanding
bookValue 8.312
Price To Book help_outline 8.03
earningsQuarterlyGrowth
netIncomeToCommon -96.75M
trailingEps -0.93%
forwardEps -1.51%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.25 3Q 2024
institutionsCount 516
lastUpdated Sept. 16, 2024, 12:42 p.m.